Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Testosterone effects on bone and frailty in men with osteoporosis

Trial Profile

Testosterone effects on bone and frailty in men with osteoporosis

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Testosterone (Primary)
  • Indications Male osteoporosis; Osteoporosis
  • Focus Pharmacodynamics

Most Recent Events

  • 01 Jun 2010 Results were published in the Journal of the American Geriatrics Society.
  • 02 May 2009 Results presented at Annual Scientific Meeting of the American Geriatrics Society
  • 15 Nov 2006 Status change

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top